China Lactic Acid and Derivative Industry Report, 2013
  • Aug./2013
  • Hard Copy
  • USD $1,800
  • Pages:57
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: LT005
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,700
  • Hard Copy + Single User License
  • USD $2,000
China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their designed annual capacity with a high idle capacity rate. In 2010-2011, China’s idle annual capacity of lactic acid reached at least 110,000 tons. The capacity and output in 2012 were estimated to be 329,000 tons and 226,000 tons respectively, up 15% and 28.4% separately from 2011.

Henan Jindan Lactic Acid Technology and Chongqing Bofei Biochemical Products possess the largest lactic acid capacity in China. In 2012, their combined capacity of the two totaled 175,000 tons, equivalent to 53.2% of China’s total lactic acid capacity. Each of other lactic acid enterprises seizes the capacity of 10,000-30,000 tons averagely.

China’s Lactic Acid Capacity and Output, 2006-2012

In China, the food and beverage industry is accustomed to use lactic acid in condiments, liquor brewery industry, milk processing and others. In 2012, the food and beverage industry consumed about 161,000 tons of lactic acid, accounting for 49.2% of China's total lactic acid consumption; 119,000 tons of lactic acid (36.1%) was applied to leather manufacturing, microelectronics, electroplating industry, polylactic acid production and other industrial fields.

By virtue of pollution-free, degradability and alternative properties (polylactic acid can replace petroleum-based materials excellently), polylactic acid has become one of the most potential derivatives in China lactic acid industry. With the completion of the technological transformation of most polylactic acid manufacturers and the operation of new production lines, China’s polylactic acid capacity reached 85,500-102,000 tons in 2012. As a giant in China polylactic acid industry, Hisun Biomaterials attained the polylactic acid capacity of approximately 30,000 tons in 2012 and it is building one 20,000 t / a polylactic acid project.

 The report covers the followings:

20120114.gif Competition pattern, market supply and demand and outlook of the global lactic acid and derivative industry;
20120114.gif Market supply and demand, competition pattern, outlook, and polylactic acid application prospect of China lactic acid and derivative industry;
20120114.gif Import and export of Chinese lactic acid and derivatives including polylactic acid, lactic acid, lactate salt and lactic ester ;
20120114.gif Operation of global lactic acid and derivative companies PURAC, GALACTIC, ADM and Cargill;
20120114.gif Operation of 15 Chinese lactic acid and derivative enterprises (including Hisun Biomaterials, COFCO Biochemical GALACTIC, Jindan Lactic Acid, Hypow Biotechnology, Bofei Biochemical Products, Kaifeng Bioengineering, Haijianuo Biological Engineering and Sanjiang Space Good Biotech).

1 Introduction to Lactic Acid and Derivatives
1.1 Definition of Lactic Acid
1.2 Chinese Industrial Policies about Lactic Acid and Derivatives
1.2.1 Lactic Acid
1.2.2 Polylactic Acid

2 Development of Global Lactic Acid and Derivative Industry 
2.1 Competition Pattern 
2.2 Market Supply and Demand 
2.3 Outlook 

3 Development of China Lactic Acid and Derivative Industry
3.1 Market Supply and Demand 
3.2 Competition Pattern 
3.3 Outlook 
3.4 Application Prospect of Polylactic Acid  
3.4.1 Pharmaceutical Field
3.4.2 Others

4 Polylactic Acid Import and Export in China
4.1 Polylactic Acid
4.2 Lactic Acid, Lactate Salt and Lactic Ester 

5 Major Lactic Acid and Derivative Companies in the World
5.1 PURAC 
5.1.1 Profile
5.1.2 Production 
5.1.3 Operation 
5.2.1 Profile
5.2.2 Development Course 
5.2.3 Operation 
5.3 ADM
5.3.1 Profile
5.3.2 Operation 
5.4 Cargill 
5.4.1 Profile
5.4.2 Lactic Acid Business 

6 Major Lactic Acid and Derivative Enterprises in China
6.1 Zhejiang Hisun Biomaterials 
6.1.1 Profile
6.1.2 Main Products 
6.1.3 Polylactic Acid Business 
6.2 Anhui COFCO Biochemical & GALACTIC 
6.2.1 Profile
6.2.2 Main Products 
6.2.3 Operation 
6.3 Henan Jindan Lactic Acid Technology
6.3.1 Profile
6.3.2 Main Products 
6.3.3 Operation 
6.3.4 R & D and Investment 
6.4 Ningxia Hypow Biotechnology 
6.4.1 Profile
6.4.2 Main Products 
6.4.3 Operation 
6.5 Chongqing Bofei Biochemical Products 
6.5.1 Profile
6.5.2 Main Products 
6.5.3 Operation 
6.6 Xiaogan Kaifeng Bioengineering    
6.6.1 Profile
6.6.2 Main Products 
6.6.3 Operation 
6.7 Yancheng Haijianuo Biological Engineering  
6.7.1 Profile
6.7.2 Main Products 
6.7.3 Operation 
6.8 Wuhan Sanjiang Space Good Biotech  
6.8.1 Profile
6.8.2 Main Products 
6.9 Other Lactic Acid and Derivative Enterprises in China
6.9.1 Shanxi Leda Biochemical    
6.9.2 Shengnongli (Huludao) Biotechnology  
6.9.3 Hunan Anhua Lactic Acid Plant
6.9.4 Musashino Chemical (China) 
6.9.5 Shenzhen Esun Industrial   
6.9.6 Nantong Jiuding Biological Engineering 
6.9.7 Yangtze Labre  
Main Lactic Acid Derivatives and Applications
Policies on Polylactic Acid Industry in China
Capacity of Major Global Lactic Acid Manufacturers, 2012
Capacity of Major Global Polylactic Acid Manufacturers, 2012
Market Share of Global Polylactic Acid Manufacturers, 2012
Consumption Structure of Global Lactic Acid (by Region), 2012
Global Polylactic Acid Capacity Distribution (by Industry), 2011
Global Polylactic Acid Output Value (by Region), 2009-2011
Global Polylactic Acid Output Value (by Region), 2012-2016E
Global Polylactic Acid Capacity, 2011-2020E
Global Lactic Acid Demand, 2010-2016E
Lactic Acid Capacity and Output in China, 2006-2012
Capacity of Major Lactic Acid Manufacturers in China, 2012
Lactic Acid Consumption Structure in China, 2012
Weekly Average Lactic Acid Price in Shanghai Zhongshan Chemical Market, 2007-Jul 2013
Market Share of Chinese Lactic Acid Enterprises, 2012
Capacity of Major Polylactic Acid Manufacturers in China, 2008 vs 2012
China’s Lactic Acid Capacity, 2013-2016E
Demand for Implantable Biomedical Products in China, 2011
Import Volume and Value of Polylactic Acid in China, 2007- Jun. 2013
Top 10 Countries of Origin by Import Volume of Polylactic Acid in China, Jan-Jun 2013
Polylactic Acid Export Volume and Value in China, 2009-Jun. 2013
Top 10 Export Destinations of Chinese Polylactic Acid, Jan-Jun., 2013
Import Volume and Value of Lactic Acid, Lactate Salt and Lactic Ester in China, 2010- Jun. 2013
Top 10 Ports by Import Volume of Lactic Acid, Lactate Salt and Lactic Ester in China, Jan-Jun., 2013
Export Volume and Value of Lactic Acid, Lactate Salt and Lactic Ester in China, 2010-Jun. 2013
Top 10 Ports by Export Volume of Lactic Acid, Lactate Salt and Lactic Ester in China, Jan-Jun., 2013
Main Products and Business Scope of PURAC
PURAC's Production Plants
Distribution of PURAC's Plants and Sales Offices
Revenue and EBIT of PURAC, 2008-2015E
Revenue Structure of PURAC (by Sector), 2011
Capital Expenditure and Return on Investment of PURAC, 2009-2012
Main Products of GALACTIC
Development Course of GALACTIC
Net Income and Growth Rate of GALACTIC, 2008-2012
Main Lactic Acid Products of ADM
Net Sales and Net Income of ADM, 2009-2011
Business Models of ADM
Global Distribution of ADM
Main Products of Cargill
Production Modes of Ingeo
Development of NatureWorks by Country, 2010-2011 
Main Products of Hisun Biomaterials
Polylactic Acid Capacity Development Course of Hisun Biomaterials
Products of COFCO Biochemical & GALACTIC 
Revenue and Net Profit Margin of COFCO Biochemical & GALACTIC, 2009-2012      
Operating Cost and Gross Margin of COFCO Biochemical & GALACTIC, 2009-2012         
Products of Jindan Lactic Acid
Revenue of Jindan Lactic Acid, 2010-2012 
Products of 50,000 t/a Polylactic Acid Project of Jindan Lactic Acid 
Average Annual Consumption of Raw Materials of 50,000 t/a Polylactic Acid Project of Jindan Lactic Acid 
Organizational Structure of Hypow Biotechnology
Main Lactic Acid Products of Hypow Biotechnology
Sales Network of Hypow Biotechnology  
Main Products of Bofei Biochemical Products
Sales Network of Bofei Biochemical Products  
Main Products of Kaifeng Bioengineering
Main Products of Haijianuo Biological Engineering
Sales Revenue of Haijianuo Biological Engineering, 2010-2015E
Main Products of Sanjiang Space Good Biotech
Main Products of Shanxi Leda Biochemical
Development Course of Musashino Chemical (China)
Branches of Shenzhen Esun Industrial 
Main Products of Nantong Jiuding Biological Engineering
Main Polylactic Acid Fiber Products of Yangtze Labre

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号